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dicted using a Markov model, which tracked cohort
movements across fracture outcome states. We ran 50
consecutive cohorts, starting each year of age 50 through
99, each with a 10-year follow up. Average cost at each
individual patient age was adjusted by osteoporosis attri-
bution rates; then the population of women within ages
50–100 was multiplied by average cost to determine total
cost by age, within each year (2000–2009). Because frac-
ture incidence rates were unavailable, costs of other frac-
tures and total costs of osteoporosis in males were esti-
mated by multiplying base year costs by the respective
population increases over time. RESULTS: Discounted
costs of osteoporosis were over $1 billion in 2000 and in-
creased to $1.21 billion (21%) by 2009. The greatest cost
increases were for age groups 50–64 and 85. Total cost
for the decade exceeded $11.1 billion. CONCLUSIONS:
Osteoporosis is predicted to have substantial and increas-
ing impacts on Florida’s healthcare resources. This infor-
mation may contribute to health policy discussions in
Florida.
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Since osteoporosis is a silent disease until fracture occurs,
identification of patients with a high lifetime risk of fur-
ther developing this disorder, using bone densitometry, is
widely recognized as the gold standard diagnostic proce-
dure. Nonetheless, measuring Bone Mineral Density (BMD)
for the whole population has proved to be either unfeasi-
ble and/or cost inefficient as public health resources are
limited. Therefore several attempts have been made to
develop tools aiming at selecting persons with low BMD
who should be referred for bone densitometry. The Sim-
ple Calculated Osteoporosis Risk Estimation (SCORE),
has been just designed for this purpose. OBJECTIVE:
The main objective of our study was to assess the poten-
tial efficiency of this instrument for a more rational use
of bone densitometry by excluding subjects who are un-
likely to need such a procedure. Our sample consisted of
4035 white women aged at least 45 years, recruited ret-
rospectively from a Belgian outpatient osteoporosis cen-
ter. BMD measures, using DEXA technology were col-
lected at the regions of the lumbar spine (L2-L4), the
femoral neck and the total hip. METHOD: At, at least
one of these sites, 47% of our sample had a low BMD
(defined as t-score  2 SD) and more than 32 % were
found osteoporotic, according to WHO definition
(t-score  2.5 SD). At the recommended SCORE cut-
point of 6, 18% of the patients would not be recom-
mended for densitometry. Among those, 10.9% were
misclassified as they did have osteoporosis at, at least one
of the considered sites. Considering each site separately,
the negative predictive errors of SCORE, when failing to
detect osteoporosis, were only 1% for the total hip, 3.2%
for the femoral neck and 8.8%for the lumbar spine.
CONCLUSIONS: We conclude that although the overall
accuracy of SCORE had demonstrated to be quite poor
as a diagnostic tool, from a resource allocation stand
point, this instrument could be used with relative confi-
dence to exclude patients who do not need a BMD mea-
surement, opening the perspective of substantial savings
in comparison to a mass screening strategy.
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Osteoporosis is a major public health problem in post-
menopausal women. Identifying patients at risk of devel-
oping an osteoporosis related fracture remains one of the
challenges of the next decades. Although it is widely rec-
ognized that the “gold standard” procedure for os-
teoporosis diagnosis is bone densitometry, economic is-
sues or availability of the densitometers may prevent its
use under a mass screening scenario. A risk assessment
instrument, the Simple Calculated Osteoporosis Risk Es-
timation (SCORE), has been developed to be used for se-
lecting women likely to have low bone mass density
(BMD) for referring for bone densitometry. Low BMD
was defined as 2 standard deviations or more below the
mean of young healthy adult. The promises shown by the
original validation of SCORE have to be further tested
on different populations. A couple of published studies
did not reach the same level of satisfaction. OBJECTIVE:
The aim of our study is to evaluate this prescreening tool
in a large sample of Caucasian women, at different levels
of BMD and at various sites of measurement. METHOD:
We gathered medical data on 4035 patients aged 45
years or more, either consulting spontaneously or re-
ferred for a BMD measurement to an outpatient os-
teoporosis center located in Liege, Belgium. BMD mea-
sures, using DEXA technology, were listed at the hip
(both total and neck) and the lumbar spine (L2-L4). RE-
SULTS: More than 47% of our sample presented with
